Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma for Early COVID-19 Pneumonia (TSUNAMI)
NCT04716556Completed
- Sponsor
- Istituto Superiore di Sanità
- Start
- Jul 2020
- Primary completion
- Jan 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) and viral pneumonia, sponsored by Istituto Superiore di Sanità. Primary endpoint: Number of patients who meet invasive mechanical ventilation or death at 30 days. Started Jul 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)viral pneumonia
Beyond the preview
Go deeper on NCT04716556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04716556.